Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $0.5814, but opened at $0.5963. Elite Pharmaceuticals shares last traded at $0.5743, with a volume of 198,149 shares traded.
Elite Pharmaceuticals Trading Down 5.1%
The stock has a market cap of $592.61 million, a P/E ratio of -55.20 and a beta of 0.10. The stock’s 50-day moving average is $0.63 and its two-hundred day moving average is $0.60. The company has a debt-to-equity ratio of 0.09, a current ratio of 7.23 and a quick ratio of 5.44.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Recommended Stories
- Five stocks we like better than Elite Pharmaceuticals
- Which Wall Street Analysts are the Most Accurate?
- Why a 20-Second Flight Test Could Unlock Billions for Vertical
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3 Smart Defensive Stocks for an Uneasy Market
- How to Buy Cheap Stocks Step by Step
- These 3 Stocks Are Using Buybacks to Signal Market Confidence
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
